Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03357627
Title A Study of TAK-659 in Combination With Venetoclax for Adult Participants With Previously Treated Non-Hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

non-Hodgkin lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

Mivavotinib + Venetoclax

Age Groups: adult | senior
Covered Countries USA | DEU | CAN


No variant requirements are available.